Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Telomeres and telomerase in hematologic neoplasia

Abstract

Normal hematopoietic cells express telomerase activity, however the presence of telomerase does not necessarily imply stable and thus unchanging telomere length. Gradual telomere loss with aging and rapid cycling of hematopoietic stem cells might contribute to immunosenescence, exhausted hematopoiesis, and increased likelihood of malignant transformation. In leukemias and lymphomas, telomere length may reflect the cellular proliferative history, prior to immortalization. The level of telomerase activity is generally influenced by the fraction of cells in the proliferative pool. Shortened telomeres and high telomerase activity almost always correlates with disease severity in hematologic neoplasias such as relapsed leukemia and high-grade lymphomas, indicating that measurement of telomere length and telomerase activity might be useful to monitor disease condition. Since the mode of action of telomerase inhibitors may require telomeric shortening before induction of apoptosis, anti-telomerase therapy might be helpful for adjuvant therapy following conventional chemotherapy, in vitro purging of neoplastic cells in stem cell transplantation, and treating minimal residual disease. Some promising areas of tissue engineering include rejuvenation of hematopoietic stem cells for improving stem cell transplants or enhancing general immunity for older patients.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Akiyama M, Hoshi Y, Sakurai H, Yamada H, Yamada O, Mizoguchi H . 1998 Bone Marrow Transplant 21: 167–171

  • Akiyama M, Asai O, Kuraishi Y, Urashima M, Hoshi Y, Sakamaki H, Yabe H, Furukawa T, Yamada O, Mizoguchi H, Yamada H . 2000 Bone Marrow Transplant 25: 441–447

  • Allsopp RC, Cheshier S, Weissman IL . 2001 J. Exp. Med. 193: 917–924

  • Arai J, Yasukawa M, Ohminami H, Kakimoto M, Hasegawa A, Fujita S . 2001 Blood 97: 2903–2907

  • Baur JA, Zou Y, Shay JW, Wright WE . 2001 Science 292: 2075–2077

  • Bearss DJ, Bearss DJ, Subler MA, Hundley JE, Troyer DA, Salinas RA, Windle JJ . 2000 Oncogene 19: 1114–1122

  • Bechter OE, Eisterer W, Pall G, Hilbe W, Kuhr T, Thaler J . 1998 Cancer Res. 58: 4918–4922

  • Bergemann J, Kuhlcke K, Fehse B, Ratz I, Ostertg W, Lother H . 1995 Nucleic Acids Res. 23: 4451–4456

  • Boultwood J, Fidler C, Kusec R, Rack K, Elliott PJ, Atoyebi O, Chapman R, Oscier DG, Wainscoat JS . 1997 Am. J. Hematol. 56: 266–271

  • Boultwood J, Peniket A, Watkins F, Shepherd P, McGale P, Richards S, Fidler C, Littlewood TJ, Wainscoat JS . 2000 Blood 96: 358–361

  • Broccoli D, Young JW, de Lange T . 1995 Proc. Natl. Acad. Sci. USA 92: 9082–9086

  • Brousset P, al Saati T, Chaouche N, Zenou RC, Schlaifer D, Chittal S, Delsol G . 1997 Blood 89: 26–31

  • Brousset P, Chaouche N, Al Saati T, Zenou RC, Delsol G . 1998 Leuk. Lymphoma 30: 189–192

  • Brummendorf TH, Holyake TL, Rufer N, Barnett MJ, Schulzer M, Eaves CJ, Eaves AC, Lansdorp PM . 2000 Blood 95: 1883–1890

  • Brummendorf TH, Maciejewski JP, Mak J, Young NS, Lansdorp PM . 2001 Blood 97: 895–900

  • Busson Le Coniat M, Brizard F, Smadja NV, Maarek O, Der Sarkissian H, Berger R . 2000 Leukemia 14: 1630–1633

  • Chiu CP, Dragowska W, Kim NW, Vaziri H, Yui J, Thomas TE, Harley CB, Lansdorp PM . 1996 Stem Cells 14: 239–248

  • Counter CM, Gupta J, Harley CB, Lebe B, Bacchetti S . 1995 Blood 85: 2315–2320

  • Cuthbert G, McCullough S, Finney R, Breese G, Bown N . 1999 Genes Chromosomes Cancer 24: 295–298

  • Daibata M, Taguchi T, Nemoto Y, Taguchi H, Miyoshi I . 1999 Blood 94: 1545–1549

  • Ely SA, Chadburn A, Dayton CM, Cesarman E, Knowles DM . 2000 Cancer 89: 445–452

  • Engelhardt M, Kumar R, Albanell J, Pettengell R, Han W, Moore MAS . 1997 Blood 90: 182–193

  • Engelhardt M, Mackebzie K, Drullinsky P, Silver RT, Moore MAS . 2000 Cancer Res. 60: 610–617

  • Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Mufti G, Bennett J . 1997 Blood 89: 2079–2088

  • Guiducci C, Cerone MA, Bacchetti S . 2001 Oncogene 20: 714–725

  • Harada K, Kurisu K, Arita K, Sadatomo T, Tahara H, Tahara E, Ide T, Uozumi T . 1999 Cancer 86: 1050–1055

  • Hatakeyama S, Osawa M, Omine M, Ishikawa F . 1999 Oncogene 18: 2085–2090

  • Hiyama K, Hirai Y, Koizumi S, Akiyama M, Hiyama E, Piatyszek MA, Shay JW, Ishioka S, Yamakodo M . 1995 J. Immunol. 155: 3711–3715

  • Holt SE, Wright WE, Shay JW . 1996 Mol. Cell. Biol. 16: 2932–2939

  • Igarashi H, Sakaguchi N . 1996 Biochem. Biophys. Res. Commun. 219: 649–655

  • Igarashi H, Sakaguchi N . 1997 Blood 89: 1299–1307

  • Iwama H, Ohyashiki K, Ohyashiki JH, Hayashi S, Kawakubo K, Shay JW, Toyama K . 1997 Cancer 79: 1552–1560

  • Iwama H, Ohyashiki K, Ohyashiki JH, Hayashi S, Yahata N, Ando K, Toyama K, Hoshika A, Takasaki M, Mori M, Shay JW . 1998 Human Genet. 102: 397–402

  • Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW . 1994 Science 266: 2011–2015

  • Lee J, Kook H, Chung I, Kim H, Park M, Kim C, Nah J, Hwang T . 1999 Bone Marrow Transplant 24: 411–415

  • Li B, Yang J, Andrews C, Chen YX, Toofanfard P, Huang RW, Horvath E, Chopra H, Raza A, Preisler HD . 2000 Leuk. Lymphoma 36: 579–587

  • Nakajima A, Tauchi T, Ohyashiki K . 2001 Leukemia 15: 989–990

  • Nilsson P, Mehle C, Remes K, Roos G . 1994 Oncogene 9: 3043–3048

  • Norrback K-F, Dahlenborg K, Carlsson R, Roos G . 1996 Blood 88: 222–229

  • Norrback KF, Roos G . 1997 Eur. J. Cancer 33: 774–780

  • Norrback KF, Enblad G, Erlanson M, Sundstrom C, Roos G . 1998 Blood 92: 567–573

  • Notaro R, Cimmino A, Tabarini D, Rotoli B, Luzzatto L . 1997 Proc. Natl. Acad. Sci. USA 94: 13782–13785

  • Ohyashiki JH, Ohyashiki K, Fujimura T, Kawakubo K, Shimamoto T, Iwabuchi A, Toyama K . 1994 Cancer Res. 54: 3557–3560

  • Ohyashiki JH, Ohyashiki K, Toyama K, Shay JW . 1996 Trends. Genet. 12: 395–396

  • Ohyashiki JH, Ohyashiki K, Iwama H, Hayashi S, Toyama K, Shay JW . 1997a Clin. Cancer Res. 3: 619–625

  • Ohyashiki K, Ohyashiki JH, Iwama H, Hayashi S, Shay JW, Toyama K . 1997b Leukemia 11: 190–194

  • Ohyashiki JH, Iwama H, Yahata N, Ando K, Hayashi S, Shay JW, Ohyashiki K . 1999 Clin. Cancer Res. 5: 1155–1160

  • Ohyashiki JH, Hayashi S, Yahata N, Iwama H, Ando K, Tauchi T, Ohyashiki K . 2001 Int. J. Oncol. 18: 593–598

  • Pan C, Xue BH, Ellis TM, Peace DJ, Diaz MO . 1997 Exp. Cell Res. 231: 346–353

  • Remes K, Norrback KF, Rosenquist R, Mehle C, Lindh J, Roos G . 2000 Br. J. Cancer 82: 601–607

  • Rufer N, Dragowska W, Thornbury G, Roosnek E, Lansdorp PM . 1998 Nat. Biotechnol. 16: 743–747

  • Rufer N, Brummendorf TH, Chpuis B, Helg C, Lansdorp PM, Poosnek E . 2001 Blood 97: 575–577

  • Sakabe H, Yahata N, Kimura T, Zeng ZZ, Minamiguchi H, Kaneko H, Mori KJ, Ohyashiki K, Ohyashiki JH, Toyama K, Abe T, Sonoda Y . 1998 Leukemia 12: 728–734

  • Shay JW, Werbin H, Wright WE . 1996 Leukemia 10: 1255–1261

  • Shay JW . 1998 Lancet 351: 153–154

  • Shay JW, Wright WE . 2000 Nat. Biotechnol. 18: 22–23

  • Steinert S, Shay JW, Wright WE . 2000 Biochem. Biophys. Res. Commun. 273: 1095–1098

  • Takeuchi K, Tashiro S, Ohtaki M, Kamada N . 1994 Jpn. J. Cancer Res. 85: 127–130

  • Tatematsu K, Nakayama J, Danbara M, Shionoya S, Sato H, Omine M, Ishikawa F . 1996 Oncogene 13: 2265–2274

  • Thomas M, Yang L, Hornsby PJ . 2000 Nat. Biotechnol. 18: 39–42

  • Trentin L, Ballon G, Ometto L, Perin A, Basso U, Chieco-Bianchi L, Semenzato G, De Rossi A . 1999 Br. J. Haematol. 106: 662–668

  • Vaziri H, Dragowska W, Allosopp RC, Thomas TE, Harley CB, Lansdrop PM . 1994 Proc. Natl. Acad. Sci. USA 91: 9857–9860

  • Vonderheide RH, Hahn WC, Schulze JL, Nadler LM . 1999 Immunity 10: 673–679

  • Weng N-P, Levine BL, June CH, Hodes RJ . 1996 J. Exp. Med. 183: 2471–2479

  • Wright WE, Shay JW, Pietyszek MA . 1995 Nucleic Acid Res. 23: 3794–3795

  • Wynn RF, Cross MA, Hatton C, Will AM, Lashford LS, Dexter TM, Testa NG . 1998 Lancet 351: 178–181

  • Xu D, Gruber A, Peterson C, Pisa P . 1998 Br. J. Haematol. 102: 1367–1375

  • Xu D, Gruber A, Bjorkholm M, Peterson C, Pisa P . 1999 Br. J. Cancer 80: 1156–1161

  • Yamada O, Oshimi K, Motoji T, Mizoguchi H . 1995 J. Clin. Invest. 95: 1117–1123

  • Yeager TR, Neumann AA, Englezou A, Huschtscha LI, Noble JR, Reddel RR . 1999 Cancer Res. 59: 4175–4179

  • Yui J, Chiu CP, Lansdorp PM . 1998 Blood 91: 3255–3262

  • Zhang W, Pietyszek MA, Kobayashi T, Estey E, Andreeff M, Deisseroth AB, Wright WE, Shay JW . 1996 Clin. Cancer Res. 2: 799–803

Download references

Acknowledgements

The authors wish to thank Profs Jerry W Shay (University of Texas Southwestern Medical Center) and Peter L Greenberg (Stanford University) for critical reading of this review.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Junko H Ohyashiki.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ohyashiki, J., Sashida, G., Tauchi, T. et al. Telomeres and telomerase in hematologic neoplasia. Oncogene 21, 680–687 (2002). https://doi.org/10.1038/sj.onc.1205075

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205075

Keywords

This article is cited by

Search

Quick links